Tom O'Connor

Associate

London

Tom is an associate in our corporate finance team, specialising in capital markets transactions.

D +44 20 7809 2849
M +44 772 117 0611

email | LinkedIn | vCard

Awards and Recognition

Associate to Watch

Chambers UK 2026: Capital Markets, AIM

“I'm impressed with his ready engagement and demonstrable knowledge”

Chambers, 2026

“Tom O'Connor is responsive with a straight-forward, no-fuss approach”

Chambers, 2026

“Found Tom O’Connor to be excellent to work with – nothing was too much trouble.”

Legal 500, 2023

Biography

Language - English
Jurisdiction - Queensland, Australia

Tom advises clients on a wide range of corporate finance transactions, including public company IPOs and secondary issues — acting for both issuers and banks — as well as private and public company acquisitions and general company law matters. He has experience working with UK, Australian, and international clients across sectors such as mining and exploration, healthcare, life sciences, and technology.

Experience

Cavendish
“Advising Cavendish in its role as nominated adviser, bookrunner and broker to MHA plc on MHA plc's initial public offering on the AIM market of the London Stock Exchange”
Dr. Falk Pharma GmbH
“Advising Dr Falk on the successful acquisition of Kynos Therapeutics Ltd in a complex, cross-border transaction”
Novacyt S.A.
“Advising Novacyt on the successful acquisition of Yourgene Health plc by recommended takeover in a Takeover Code governed transaction effected by a court-sanctioned scheme of arrangement”

Liberum Capital
“Advising Liberum Capital on its merger with Panmure Gordon to create the UK's largest independent investment bank” Stephenson Harwood advises Liberum on Panmure Gordon merger